Myriad Genetics - 24 Year Stock Price History | MYGN

Historical daily share price chart and data for Myriad Genetics since 1995 adjusted for splits. The latest closing stock price for Myriad Genetics as of June 18, 2019 is 24.19.
  • The all-time high Myriad Genetics stock price is 61.23, which is 153.1% above the current share price.
  • The Myriad Genetics 52-week high stock price is 50.34, which is 108.1% above the current share price.
  • The Myriad Genetics 52-week low stock price is 23.45, which is 3.1% below the current share price.
  • The average Myriad Genetics stock price for the last 52 weeks is 35.22.
Myriad Genetics Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2019 29.6356 29.0000 35.0000 23.4500 24.1900 -16.79%
2018 37.0251 34.9100 50.3400 27.2300 29.0700 -15.36%
2017 25.3318 16.9300 37.1400 15.4000 34.3450 106.03%
2016 28.9086 42.8300 42.8300 16.2600 16.6700 -61.38%
2015 36.9074 34.6100 46.1600 30.9400 43.1600 26.72%
2014 35.2888 21.7200 42.2100 21.0300 34.0600 62.35%
2013 27.1721 27.6800 34.2600 20.7900 20.9800 -23.01%
2012 25.3547 21.0000 30.6500 20.3600 27.2500 30.13%
2011 20.8191 22.2300 25.5300 17.8600 20.9400 -8.32%
2010 19.8918 26.6600 26.9200 14.4900 22.8400 -12.46%
2009 31.4194 32.5829 43.8378 22.8500 26.0900 -17.37%
2008 25.1092 21.9856 33.8456 16.5726 31.5727 42.74%
2007 19.6255 14.9382 28.0323 14.8810 22.1190 48.31%
2006 12.2075 10.3019 15.0335 10.0446 14.9144 50.48%
2005 9.2405 10.5401 12.3318 7.2428 9.9111 -7.60%
2004 7.9792 6.4708 11.3931 5.8085 10.7260 75.04%
2003 6.1286 7.1522 8.5388 4.0979 6.1278 -11.92%
2002 11.7849 24.0107 24.0107 6.3612 6.9569 -72.26%
2001 24.3898 33.1166 36.8094 12.3556 25.0828 -36.39%
2000 31.2656 10.8999 61.2299 9.8873 39.4302 259.78%
1999 3.4556 2.5326 11.1977 2.0549 10.9594 360.00%
1998 3.7612 5.7775 6.0158 1.7869 2.3825 -58.76%
1997 6.6744 5.7775 10.8117 5.1819 5.7775 -3.96%
1996 6.1546 7.0283 8.3983 4.1098 6.0158 -22.62%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $1.817B $0.773B
Myriad Genetics, Inc. is focused on revolutionizing patient care through the discovery, development and marketing of transformative molecular diagnostic tests that address pressing clinical needs across multiple medical specialties. Myriad is the pioneer and leader in molecular diagnostics, offering innovative products that transform patients' lives. These products include leading molecular diagnostic tests for hereditary cancer, urological cancer, lung cancer, autoimmune disorders and other diseases. Myriad has invested heavily in educating patients and healthcare professionals about the role genes and proteins play in disease. Myriad's hereditary cancer genetic testing, which helps healthcare professionals better manage and tailor medical care. Myriad is expanding their reach and increasing their impact on patient care by introducing new molecular diagnostic and companion diagnostic tests for a growing number of diseases.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $108.806B 12.30
Gilead Sciences (GILD) United States $85.546B 10.39
Celgene (CELG) United States $68.622B 11.63
Illumina (ILMN) United States $51.613B 59.81
Biogen (BIIB) United States $44.941B 8.53
Vertex Pharmaceuticals (VRTX) United States $44.509B 53.80
Regeneron Pharmaceuticals (REGN) United States $33.983B 15.97
Alexion Pharmaceuticals (ALXN) United States $26.940B 15.25
Incyte (INCY) United States $17.550B 71.17
BioMarin Pharmaceutical (BMRN) United States $15.072B 0.00
Exact Sciences (EXAS) United States $14.452B 0.00
Seattle Genetics (SGEN) United States $11.552B 0.00
Array BioPharma (ARRY) United States $10.298B 0.00
Sarepta Therapeutics (SRPT) United States $9.423B 0.00
QIAGEN (QGEN) Netherlands $8.939B 29.36
Bio-Rad Laboratories (BIO.B) United States $8.674B 45.98
Bio-Techne Corp (TECH) United States $7.848B 53.55
Guardant Health (GH) United States $7.801B 0.00
Alnylam Pharmaceuticals (ALNY) United States $7.617B 0.00
Bluebird Bio (BLUE) United States $6.764B 0.00
Exelixis (EXEL) United States $6.235B 15.89
Amarin (AMRN) Ireland $6.204B 0.00
Galapagos (GLPG) Belgium $6.199B 0.00
Ascendis Pharma (ASND) Denmark $5.393B 0.00
BeiGene (BGNE) Cayman Islands $5.317B 0.00
Moderna (MRNA) United States $5.189B 0.00
Blueprint Medicines (BPMC) United States $4.614B 0.00
ARGENX SE-ADR (ARGX) Netherlands $4.051B 0.00
Spark Therapeutics (ONCE) United States $3.829B 0.00
China Biologic Products (CBPO) China $3.666B 23.28
ACADIA Pharmaceuticals (ACAD) United States $3.665B 0.00
Repligen (RGEN) United States $3.660B 91.18
Mirati Therapeutics (MRTX) United States $3.620B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.500B 0.00
Alkermes (ALKS) Ireland $3.480B 0.00
Allogene Therapeutics (ALLO) United States $3.330B 0.00
MorphoSys AG Unsponsored ADR (MOR) Germany $3.113B 0.00
UniQure (QURE) Netherlands $3.067B 0.00
Global Blood Therapeutics (GBT) United States $3.059B 0.00
Arena Pharmaceuticals (ARNA) United States $2.837B 5.76
Amicus Therapeutics (FOLD) United States $2.779B 0.00
Lion Biotechnologies (IOVA) United States $2.711B 0.00
Medicines (MDCO) United States $2.647B 0.00
Reata Pharmaceuticals (RETA) United States $2.551B 0.00
Biohaven Pharmaceutical Holding (BHVN) United States $2.547B 0.00
Intercept Pharmaceuticals (ICPT) United States $2.505B 0.00
Immunomedics (IMMU) United States $2.500B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $2.490B 0.00
Halozyme Therapeutics (HALO) United States $2.351B 0.00
Emergent Biosolutions (EBS) United States $2.329B 20.23
NeoGenomics (NEO) United States $2.301B 150.63
Akcea Therapeutics (AKCA) United States $2.263B 0.00
MyoKardia (MYOK) United States $2.204B 0.00
Ligand Pharmaceuticals (LGND) United States $2.190B 18.14
Acceleron Pharma (XLRN) United States $2.021B 0.00
Insmed (INSM) United States $1.965B 0.00
Genomic Health (GHDX) United States $1.931B 41.02
REGENXBIO (RGNX) United States $1.884B 0.00
Allakos (ALLK) United States $1.867B 0.00
Denali Therapeutics (DNLI) United States $1.867B 0.00
Zai Lab Unsponsored ADR (ZLAB) China $1.856B 0.00
AnaptysBio (ANAB) United States $1.817B 0.00
Audentes Therapeutics (BOLD) United States $1.765B 0.00
Cambrex (CBM) United States $1.454B 18.38
Nabriva Therapeutics AG (NBRV) Ireland $1.443B 0.00
Innoviva (INVA) United States $1.441B 3.99
Alector (ALEC) United States $1.402B 0.00
Gossamer Bio (GOSS) United States $1.390B 0.00
Apellis Pharmaceuticals (APLS) United States $1.382B 0.00
Coherus BioSciences (CHRS) United States $1.356B 0.00
Aimmune Therapeutics (AIMT) United States $1.284B 0.00
Orchard Therapeutics Sponsored ADR (ORTX) United Kingdom $1.255B 0.00
Fate Therapeutics (FATE) United States $1.246B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.243B 0.00
Eidos Therapeutics (EIDX) United States $1.209B 0.00
Athenex (ATNX) United States $1.194B 0.00
Rubius Therapeutics (RUBY) United States $1.150B 0.00
Epizyme (EPZM) United States $1.128B 0.00
Sangamo Therapeutics (SGMO) United States $1.126B 0.00
Editas Medicine (EDIT) United States $1.113B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.082B 0.00
Alder BioPharmaceuticals (ALDR) United States $1.040B 0.00
CORTEXYME INC (CRTX) United States $1.026B 0.00
Atara Biotherapeutics (ATRA) United States $1.022B 0.00
Codexis (CDXS) United States $0.970B 0.00
RA PHARMCTL INC (RARX) United States $0.962B 0.00
WAVE Life Sciences (WVE) Singapore $0.940B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.928B 0.00
NGM Biopharmaceuticals (NGM) United States $0.918B 0.00
Deciphera Pharmaceuticals (DCPH) United States $0.881B 0.00
ANI Pharmaceuticals (ANIP) United States $0.873B 15.49
Inotek Pharmaceuticals (RCKT) United States $0.851B 0.00
Principia Biopharma (PRNB) United States $0.841B 0.00
Twist Bioscience (TWST) United States $0.826B 0.00
Retrophin (RTRX) United States $0.822B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.789B 37.25
Cara Therapeutics (CARA) United States $0.789B 0.00
Rhythm Pharmaceuticals (RYTM) United States $0.786B 0.00
Intra-Cellular Therapies (ITCI) United States $0.780B 0.00
Axsome Therapeutics (AXSM) United States $0.772B 0.00
GENFIT Unsponsored ADR (GNFT) France $0.771B 0.00
Clovis Oncology (CLVS) United States $0.748B 0.00
Kura Oncology (KURA) United States $0.744B 0.00
G1 THERAPEUTICS (GTHX) United States $0.740B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $0.731B 0.00
Adverum Biotechnologies (ADVM) United States $0.730B 0.00
Vericel (VCEL) United States $0.725B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.711B 0.00
Arvinas (ARVN) United States $0.709B 0.00
MeiraGTx Holdings (MGTX) United States $0.691B 0.00
Myovant Sciences (MYOV) United Kingdom $0.677B 0.00
Intellia Therapeutics (NTLA) United States $0.671B 0.00
Zymeworks (ZYME) Canada $0.662B 0.00
Stemline Therapeutics (STML) United States $0.655B 0.00
Zealand Pharma (ZEAL) Denmark $0.643B 7.51
Autolus Therapeutics Sponsored ADR (AUTL) United Kingdom $0.637B 0.00
Precision BioSciences (DTIL) United States $0.632B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.627B 0.00
Cytokineticsorporated (CYTK) United States $0.621B 0.00
Heska (HSKA) United States $0.610B 62.48
Cellectis (CLLS) France $0.607B 0.00
Viking Therapeutics (VKTX) United States $0.586B 0.00
Anika Therapeutics (ANIK) United States $0.576B 19.67
Puma Biotechnology (PBYI) United States $0.526B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.525B 0.00
Revance Therapeutics (RVNC) United States $0.498B 0.00
Scholar Rock Holding (SRRK) United States $0.494B 0.00
DBV Technologies (DBVT) France $0.492B 0.00
BeyondSpring (BYSI) United States $0.489B 0.00
CytomX Therapeutics (CTMX) United States $0.489B 0.00
UROGEN PHARMA (URGN) United States $0.489B 0.00
Mesoblast (MESO) Australia $0.465B 0.00
Magenta Therapeutics (MGTA) United States $0.460B 0.00
ObsEva SA (OBSV) Switzerland $0.457B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.456B 0.00
Synthorx (THOR) United States $0.450B 0.00
Sorrento Therapeutics (SRNE) United States $0.446B 0.00
Kodiak Sciences (KOD) United States $0.443B 0.00
Provention Bio (PRVB) United States $0.424B 0.00
Krystal Biotech (KRYS) United States $0.415B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.413B 0.00
Replimune (REPL) United States $0.413B 0.00
Kaleido Biosciences (KLDO) $0.412B 0.00
MediciNova (MNOV) United States $0.410B 0.00
Arcus Biosciences (RCUS) United States $0.403B 0.00
UNITY Biotechnology (UBX) $0.393B 0.00
AC Immune SA (ACIU) Switzerland $0.392B 25.22
Prothena (PRTA) Ireland $0.388B 0.00
BioDelivery Sciences (BDSI) United States $0.387B 0.00
Agenus (AGEN) United States $0.387B 0.00
Albireo Pharma (ALBO) United States $0.384B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.383B 0.00
NuCana Sponsored ADR (NCNA) United Kingdom $0.378B 0.00
Sinovac Biotech (SVA) China $0.371B 0.00
Acorda Therapeutics (ACOR) United States $0.370B 6.51
Gritstone Oncology (GRTS) United States $0.368B 0.00
PDL BioPharma (PDLI) United States $0.358B 8.54
Biofrontera AG Sponsored ADR (BFRA) Germany $0.358B 0.00
Senesco Technologies (ELOX) United States $0.355B 0.00
Stealth BioTherapeutics Sponsored ADR (MITO) United States $0.343B 0.00
ResTORbio (TORC) United States $0.338B 0.00
NEXTCURE INC (NXTC) United States $0.332B 0.00
AVROBIO (AVRO) United States $0.326B 0.00
Kindred Biosciences (KIN) United States $0.320B 0.00
LogicBio Therapeutics (LOGC) United States $0.313B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.305B 0.00
Merus (MRUS) Netherlands $0.302B 0.00
PHASEBIO PHARMA (PHAS) United States $0.301B 0.00
Cyclerion Therapeutics (CYCN) United States $0.295B 0.00
Palatin Technologies (PTN) United States $0.278B 0.00
Protagonist Therapeutics (PTGX) United States $0.277B 0.00
Cellular Biomedicine (CBMG) United States $0.274B 0.00
Geron (GERN) United States $0.274B 0.00
Athersys (ATHX) United States $0.274B 0.00
Syros Pharmaceuticals (SYRS) United States $0.272B 0.00
Dynavax Technologies (DVAX) United States $0.267B 0.00
Abeona Therapeutics (ABEO) United States $0.264B 0.00
XBiotech (XBIT) United States $0.263B 0.00
Chiasma (CHMA) United States $0.257B 0.00
Sutro Biopharma (STRO) United States $0.255B 0.00
Inovio Pharmaceuticals (INO) United States $0.253B 0.00
Constellation Pharmaceuticals (CNST) United States $0.248B 0.00
Urovant Sciences (UROV) United States $0.247B 0.00
Synlogic (SYBX) United States $0.241B 0.00
Evelo Biosciences (EVLO) United States $0.241B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.240B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.235B 0.00
BICYCLE THERAPT (BCYC) United Kingdom $0.234B 0.00
Five Prime Therapeutics (FPRX) United States $0.232B 0.00
MannKind (MNKD) United States $0.231B 0.00
Neothetics (EVFM) United States $0.230B 0.00
Celcuity (CELC) United States $0.230B 0.00
AXCELLA HEALTH (AXLA) United States $0.229B 0.00
Kadmon Holdings (KDMN) United States $0.225B 0.00
Kamada (KMDA) Israel $0.221B 8.58
Cerecor (CERC) United States $0.220B 0.00
ADMA Biologics Inc (ADMA) United States $0.220B 0.00
Avid Bioservices (CDMO) United States $0.220B 0.00
ChromaDex (CDXC) United States $0.219B 0.00
Pfenex (PFNX) United States $0.219B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.214B 0.00
IDEAYA BIOSCI (IDYA) United States $0.213B 0.00
Enochian BioSciences (ENOB) United States $0.211B 0.00
Spero Therapeutics (SPRO) United States $0.210B 0.00
Cel-Sci (CVM) United States $0.206B 0.00
Enzo Biochem (ENZ) United States $0.204B 0.00
Eiger BioPharmaceuticals (EIGR) United States $0.202B 0.00
Affimed (AFMD) Germany $0.202B 0.00
Kala Pharmaceuticals (KALA) United States $0.190B 0.00
Mersana Therapeutics (MRSN) United States $0.187B 0.00
Arsanis (XFOR) United States $0.183B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.183B 0.00
Strongbridge Biopharma (SBBP) United States $0.180B 10.41
Compugen (CGEN) Israel $0.178B 0.00
Solid Biosciences (SLDB) United States $0.177B 0.00
HOOKIPA PHARMA (HOOK) United States $0.177B 0.00
Gamida Cell (GMDA) Israel $0.174B 0.00
CorMedix Inc (CRMD) United States $0.173B 0.00
BioXcel Therapeutics (BTAI) United States $0.171B 0.00
OvaScience (MLND) United States $0.170B 0.00
Dyadic (DYAI) United States $0.167B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.167B 0.00
Cue Biopharma (CUE) United States $0.165B 0.00
Liquidia Technologies (LQDA) United States $0.162B 0.00
OSMOTICA PHARM (OSMT) United States $0.159B 0.00
Anavex Life Sciences (AVXL) United States $0.158B 0.00
Intec Pharma (NTEC) Israel $0.158B 0.00
Kezar Life Sciences (KZR) United States $0.155B 0.00
APPLIED THERAPT (APLT) United States $0.154B 0.00
BioTime (BTX) United States $0.154B 10.30
Checkpoint Therapeutics (CKPT) United States $0.153B 0.00
Mustang Bio (MBIO) United States $0.152B 0.00
Aduro Biotech (ADRO) United States $0.151B 0.00
Menlo Therapeutics (MNLO) United States $0.151B 0.00
XOMA (XOMA) United States $0.149B 0.00
SESEN BIO, INC (SESN) United States $0.143B 0.00
TOCAGEN INC (TOCA) United States $0.138B 0.00
TREVI THERAPTCS (TRVI) United States $0.137B 0.00
Celyad SA (CYAD) Belgium $0.133B 0.00
Verastem (VSTM) United States $0.129B 0.00
Eton Pharmaceuticals (ETON) United States $0.127B 0.00
Axovant Sciences (AXGT) United States $0.126B 0.00
Erytech Pharma SA Sponsored ADR (ERYP) France $0.124B 0.00
VolitionRX (VNRX) Singapore $0.121B 0.00
Novavax (NVAX) United States $0.120B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.117B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.116B 0.00
Fortress Biotech (FBIO) United States $0.116B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.115B 0.00
Aptose Biosciences (APTO) Canada $0.112B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.112B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.106B 0.00
INmune Bio (INMB) United States $0.106B 0.00
Tiziana Life Sciences Sponsored ADR (TLSA) United Kingdom $0.105B 0.00
Equillium (EQ) United States $0.104B 0.00
Arbutus Biopharma (ABUS) Canada $0.103B 0.00
NantKwest (NK) United States $0.103B 0.00
Trevena (TRVN) United States $0.103B 0.00
Aptinyx (APTX) United States $0.101B 0.00
Seres Therapeutics (MCRB) United States $0.101B 0.00
Selecta Biosciences (SELB) United States $0.099B 0.00
Allena Pharmaceuticals (ALNA) United States $0.098B 0.00
Catalyst Biosciences (CBIO) United States $0.090B 0.00
InflaRx (IFRX) Germany $0.086B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.085B 0.00
Idera Pharmaceuticals (IDRA) United States $0.083B 0.00
Pluristem Therapeutics (PSTI) Israel $0.082B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.080B 0.00
Unum Therapeutics (UMRX) United States $0.078B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.075B 0.00
Cohbar (CWBR) United States $0.075B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $0.073B 0.00
Signal Genetics (MGEN) United States $0.073B 0.00
Applied Genetic Technologies (AGTC) United States $0.073B 39.90
VTv Therapeutics (VTVT) United States $0.072B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.072B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.070B 0.00
Cocrystal Pharma (COCP) United States $0.070B 73.33
Orgenesis (ORGS) United States $0.068B 0.00
ARAVIVE, INC (ARAV) United States $0.066B 0.00
OVID THERAPEUTC (OVID) United States $0.065B 0.00
Alimera Sciences (ALIM) United States $0.065B 0.00
Alcobra (ARCT) United States $0.065B 0.00
Hoth Therapeutics (HOTH) United States $0.065B 0.00
Prima BioMed (IMMP) Australia $0.065B 0.00
VBI Vaccines (VBIV) United States $0.063B 0.00
ScPharmaceuticals (SCPH) United States $0.063B 0.00
Protalix BioTherapeutics (PLX) Israel $0.063B 0.00
Vaccinex (VCNX) United States $0.060B 0.00
Eyenovia (EYEN) United States $0.059B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.058B 0.00
NewLink Genetics (NLNK) United States $0.057B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.057B 0.00
Oncobiologics (OTLK) United States $0.056B 0.00
Organovo Holdings (ONVO) United States $0.055B 0.00
Proteostasis Therapeutics (PTI) United States $0.053B 0.00
Moleculin Biotech (MBRX) United States $0.052B 0.00
Ophthotech (ISEE) United States $0.052B 0.00
Zosano Pharma (ZSAN) United States $0.050B 0.00
Curis (CRIS) United States $0.050B 0.00
AEterna Zentaris (AEZS) United States $0.049B 0.00
Apricus Biosciences (SEEL) United States $0.047B 0.00
AquaBounty Technologies (AQB) United States $0.046B 0.00
DiaMedica Therapeutics (DMAC) United States $0.044B 0.00
Vascular Biogenics (VBLT) Israel $0.044B 0.00
Bellerophon Therapeutics (BLPH) United States $0.044B 0.00
Entera Bio (ENTX) Israel $0.043B 0.00
Cidara Therapeutics (CDTX) United States $0.043B 0.00
INNOVATE BIOPHARMACEUTICALS, INC (INNT) United States $0.040B 0.00
Aptevo Therapeutics (APVO) United States $0.040B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.039B 0.00
Clearside Biomedical (CLSD) United States $0.039B 0.00
BiondVax Pharmaceuticals (BVXV) Israel $0.039B 0.00
Evogene (EVGN) Israel $0.038B 0.00
Celsion (CLSN) United States $0.037B 0.00
Celldex Therapeutics (CLDX) United States $0.036B 0.00
VIVUS (VVUS) United States $0.035B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.035B 0.00
Leap Therapeutics (LPTX) United States $0.035B 0.00
Oncolytics Biotech (ONCY) Canada $0.034B 0.00
AZURRX BIOPHARM (AZRX) United States $0.033B 0.00
VistaGen Therapeutics (VTGN) United States $0.032B 0.00
Anchiano Therapeutics Sponsored ADR (ANCN) Israel $0.032B 0.00
Edge Therapeutics (PDSB) United States $0.032B 0.00
Sienna Biopharmaceuticals (SNNA) United States $0.031B 0.00
Aytu Bioscience (AYTU) United States $0.030B 0.00
Caladrius Biosciences (CLBS) United States $0.030B 0.00
Bionano Genomics (BNGO) United States $0.028B 0.00
Bison Capital Acquisition (XYN) China $0.025B 0.00
Histogenics (HSGX) United States $0.023B 0.00
Oragenics (OGEN) United States $0.023B 0.00
GENPREX INC (GNPX) United States $0.022B 0.00
GTx (ONCT) United States $0.022B 0.00
Sophiris Bio (SPHS) United States $0.021B 0.00
Rexahn Pharmaceuticals (REXN) United States $0.021B 0.00
Titan Pharmaceuticals (TTNP) United States $0.020B 0.00
Adial Pharmaceuticals (ADIL) United States $0.020B 0.00
Fibrocell Science Inc (FCSC) United States $0.019B 0.00
Vical (VICL) United States $0.019B 0.00
TRACON Pharmaceuticals (TCON) United States $0.019B 0.00
OncoSec Medical (ONCS) United States $0.018B 0.00
Pulmatrix (PULM) United States $0.018B 0.00
Cleveland BioLabs (CBLI) United States $0.017B 0.00
Novelion Therapeutics (NVLN) Canada $0.016B 0.00
IBio (IBIO) United States $0.016B 0.00
ATyr Pharma (LIFE) United States $0.016B 0.00
Gemphire Therapeutics (GEMP) United States $0.014B 0.00
Aileron Therapeutics (ALRN) United States $0.013B 0.00
TrovaGene (TROV) United States $0.013B 0.00
Novogen (KZIA) Australia $0.013B 0.00
MYOS RENS Technology (MYOS) United States $0.013B 0.00
Prana Biotechnology (ATHE) Australia $0.012B 0.00
Motif Bio Plc (MTFB) United States $0.012B 0.00
Advaxis (ADXS) United States $0.012B 0.00
Soligenix (SNGX) United States $0.012B 0.00
Dare Bioscience (DARE) United States $0.010B 0.00
Genetic Technologies (GENE) Australia $0.010B 0.00
RestorGenex (DFFN) United States $0.010B 0.00
Vital Therapies (IMUX) United States $0.010B 0.00
Therapix Biosciences (TRPX) Israel $0.010B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.010B 0.00
Hemispherx BioPharma (HEB) United States $0.009B 0.00
Flex Pharma (FLKS) United States $0.009B 0.00
IMMURON LTD (IMRN) Australia $0.009B 0.00
Benitec Biopharma (BNTC) Australia $0.009B 0.00
Synthetic Biologics (SYN) United States $0.009B 0.00
Tenax Therapeutics (TENX) United States $0.008B 0.00
Proteon Therapeutics (PRTO) United States $0.008B 0.00
BioPharmX (BPMX) United States $0.008B 0.00
Neuralstem (CUR) United States $0.007B 0.00
ContraVir Pharmaceuticals Inc (CTRV) United States $0.007B 0.00
ARCA Biopharma (ABIO) United States $0.007B 0.00
AmpliPhi Biosciences (ARMP) United States $0.007B 0.00
Cytori Therapeutics Inc (CYTX) United States $0.006B 0.00
Galena Biopharma (SLS) United States $0.004B 0.00
Stellar Biotechnologies (EDSA) United States $0.003B 0.00
Cellect Biotechnology (APOP) Israel $0.003B 0.00
Horizon Pharma Public (HZNP) Ireland $0.000B 0.00